Newsfile Corp
07 Nov 2025, 15:30 UTC · 49w ago
Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762
Verdict
Headline takes no side. We score PHIO +0.30 — moderately bullish.
- Expected · PHIO
+0.30moderately bullish
−1 bearish0bullish +1More positive than 64% of ticker scores this week
- Actual





